Citation 74705

ACHENBACH,H: RENNER,C: WAIBEL,R:. (1995). THE HEXALOBINES, DIPRENYLATED INDOLES FROM HEXALOBUS CRISPIFLORUS AND HEXALOBUS MONOPETALUS.. 1995(7)

Citation Details

Title	THE HEXALOBINES, DIPRENYLATED INDOLES FROM HEXALOBUS CRISPIFLORUS AND HEXALOBUS MONOPETALUS.
Authors	ACHENBACH,H: RENNER,C: WAIBEL,R:
Year	1995
Volume	1995
Issue	7

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (2)

Hexalobus crispiflorus (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE A,3-5:	None
2	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-5:	INACTIVE
3	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-5:	INACTIVE
4	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-5:	INACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-5:	INACTIVE
6	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-5:	EQUIVOCAL
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE A,3-6:	None
8	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-6:	INACTIVE
9	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-6:	INACTIVE
10	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-6:	INACTIVE
11	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-6:	INACTIVE
12	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE A,3-6:	EQUIVOCAL
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE B,3-5:	None
14	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B,3-5:	INACTIVE
15	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B,3-5:	INACTIVE
16	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B,3-5:	INACTIVE
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B,3-5:	INACTIVE
18	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B,3-5:	EQUIVOCAL
19	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE B	None
20	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B	WEAK ACTIVITY
21	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B	INACTIVE
22	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B	EQUIVOCAL
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B	INACTIVE
24	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE B	EQUIVOCAL
25	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE C,3-5:	None
26	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-5:	EQUIVOCAL
27	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-5:	ACTIVE
28	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-5:	ACTIVE
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-5:	INACTIVE
30	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-5:	EQUIVOCAL
31	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE C,3-6:	None
32	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-6:	EQUIVOCAL
33	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-6:	INACTIVE
34	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-6:	ACTIVE
35	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-6:	INACTIVE
36	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE C,3-6:	EQUIVOCAL
37	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE D,3-5:	None
38	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE D,3-5:	WEAK ACTIVITY
39	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE D,3-5:	ACTIVE
40	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE D,3-5:	ACTIVE
41	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE D,3-5:	INACTIVE
42	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE D,3-5:	EQUIVOCAL
43	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE E,3-5:	None
44	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE E,3-5:	INACTIVE
45	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE E,3-5:	EQUIVOCAL
46	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE E,3-5:	WEAK ACTIVITY
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE E,3-5:	INACTIVE
48	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HEXALOBINE E,3-5:	EQUIVOCAL
49	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,3-[3'-HYDROXY-3'-METHYL-1'-PALMITOYL-OXY-BUT-2'(R)-OL]-6-(3''-METHYL-2''-BUTENYL):	None
50	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,3-[3'-HYDROXY-3'-METHYL-1'-OLEOYL-OXY-BUT-2-(R)-OL]-6-(3''-METHYL-2''-BUTENYL):	None
51	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,3-[3'-HYDROXY-1'-CIS-CIS-LINOLEOYL-OXY-3'-METHYL-BUT-2'-OL)-6-(3''-METHYL-2''-BUTENYL):	None
52	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,5-[2''(S)-3''-EPOXY-3''-METHYL-BUTYL]-3-[3'-HYDROXY-3'-METHYL-1'-PALMITOYL-OXY-BUT-2'(S)-OL]:	None
53	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,5-[2''-(S)-3''-EPOXY-3''-METHYL-BUTYL]-3-[3'-HYDROXY-3'-METHYL-1'-OLEOYL-OXY-BUT-2'(S)-OL]:	None
54	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,5-[2''(S)-3''-EPOXY-3''-METHYL-BUTYL]-3-[3'-HYDROXY-1'-CIS-CIS-LINOLEOYL-OXY-3'-METHYL-BUT-2'(S)-OL):	None
55	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEXALOBINE E,2-3:	None
56	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	INDOLE,3-[2'(R)-3'-DIHYDROXY-3'-METHYL-BUTYL]-5-[2''(S)-3''-EPOXY-3''-METHYL-BUTYL]:	None
57	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,3-[2'(S)-3'-DIHYDROXY-3'-METHYL-BUTYL]-6-(3''-METHYL-2''-BUTENYL):	None
58	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(S)-3'-DIHYDROXY-3'-METHYL-BUTYL]-6-(3''-METHYL-2''-BUTENYL):	ACTIVE
59	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(S)-3'-DIHYDROXY-3'-METHYL-BUTYL]-6-(3''-METHYL-2''-BUTENYL):	ACTIVE
60	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(S)-3'-DIHYDROXY-3'-METHYL-BUTYL]-6-(3''-METHYL-2''-BUTENYL):	ACTIVE
61	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(S)-3'-DIHYDROXY-3'-METHYL-BUTYL]-6-(3''-METHYL-2''-BUTENYL):	INACTIVE
62	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(S)-3'-DIHYDROXY-3'-METHYL-BUTYL]-6-(3''-METHYL-2''-BUTENYL):	EQUIVOCAL
63	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,3-[2'(R)-3'-DIHYDROXY-3'-METHYL-BUTYL]-5-(3''-METHYL-CRONONYL):	None
64	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(R)-3'-DIHYDROXY-3'-METHYL-BUTYL]-5-(3''-METHYL-CRONONYL):	INACTIVE
65	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(R)-3'-DIHYDROXY-3'-METHYL-BUTYL]-5-(3''-METHYL-CRONONYL):	INACTIVE
66	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(R)-3'-DIHYDROXY-3'-METHYL-BUTYL]-5-(3''-METHYL-CRONONYL):	EQUIVOCAL
67	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(R)-3'-DIHYDROXY-3'-METHYL-BUTYL]-5-(3''-METHYL-CRONONYL):	INACTIVE
68	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INDOLE,3-[2'(R)-3'-DIHYDROXY-3'-METHYL-BUTYL]-5-(3''-METHYL-CRONONYL):	EQUIVOCAL
69	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	INDOLE,3-[1'-3'-DIHYDROXY-3'-METHYL-BUT-2'(R)-OL]-6-(3''-METHYL-2''-BUTENYL):	None

Hexalobus monopetalus (ANNONACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF	HEXALOBINE A,3-6:HEXALOBINE C,3-6:HEXALOBINE B,3-6:	None

Citation 74705

Citation Details

Summary

Organisms and Their Experiments (2)

Hexalobus crispiflorus (ANNONACEAE)

Hexalobus monopetalus (ANNONACEAE)

Show SPARQL Queries (1)

Query 1